| Breakdown | TTM | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.57B | 1.23B | 1.63B | 1.24B | 1.07B | 1.09B |
| Gross Profit | 1.49B | 1.23B | 1.54B | 1.16B | 976.80M | 998.82M |
| EBITDA | 801.58M | 720.77M | 682.64M | 534.38M | 513.76M | 453.68M |
| Net Income | 477.87M | 400.48M | 392.27M | 373.61M | 342.59M | 301.57M |
Balance Sheet | ||||||
| Total Assets | 8.28B | 7.87B | 7.56B | 6.46B | 5.09B | 5.08B |
| Cash, Cash Equivalents and Short-Term Investments | 250.42M | 249.84M | 295.38M | 395.40M | 650.35M | 894.89M |
| Total Debt | 3.43B | 3.27B | 3.10B | 2.15B | 1.14B | 1.27B |
| Total Liabilities | 3.88B | 3.62B | 3.49B | 2.57B | 1.46B | 1.66B |
| Stockholders Equity | 4.39B | 4.25B | 4.07B | 3.89B | 3.63B | 3.42B |
Cash Flow | ||||||
| Free Cash Flow | 272.83M | 121.06M | -764.61M | -1.07B | 43.46M | 1.06B |
| Operating Cash Flow | 288.02M | 156.98M | -637.40M | -1.02B | 74.39M | 1.09B |
| Investing Cash Flow | -16.34M | -39.97M | -121.20M | -9.14M | -51.98M | 37.05M |
| Financing Cash Flow | -251.96M | -143.16M | 644.49M | 827.42M | -298.93M | -1.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$3.37B | 6.57 | 11.00% | 6.92% | 4.78% | 24.02% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | HK$1.37B | 4.31 | 8.51% | 7.43% | 1.11% | 3.98% | |
58 Neutral | HK$709.71M | 1.97 | 12.27% | 9.77% | 16.56% | 110.71% | |
52 Neutral | HK$1.35B | 21.21 | 1.71% | ― | 252.77% | -62.06% | |
45 Neutral | HK$1.76B | 290.58 | 1.29% | 0.27% | -7.88% | -28.43% |